Ozempic about to hit shelves… but there’s a catch

The TGA has announced that supplies of Ozempic (semaglutide) have begun being distributed—but pharmacies will have to be subject to purchasing limits Following skyrocketing demand for Ozempic due at least in part to its popular off-label use as a weight loss drug, Novo Nordisk had told the TGA that it would be unavailable in Australia

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Chemist Warehouse launches Optometrist Warehouse
Next World news wrapup: 16 February 2023